Evidence map›Paper›PMID 20531308›Full record

ArticleOncogene2010

The NADPH oxidases NOX4 and DUOX2 regulate cell cycle entry via a p53-dependent pathway.

A Salmeen, B O Park, T Meyer

Open access · greenAbstract read
In one paragraph

Article in Oncogene, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. HAntioxidants (Basel, Switzerland) · 2019
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

A SalmeenDepartment of Chemical and Systems Biology, Stanford University School of Medicine Clark Center W200, Stanford, CA, USA. asalmeen@lbl.gov
B O Park
T Meyer
Stanford University · US

Funding

Dissection of the Modular Structure of Cancer Signaling SystemsR33CA120732 · NCI · STANFORD UNIVERSITY · PI MEYER, TOBIAS · 2008 to 2010
$935k
NCI NIH HHS R33 CA120732
6 · The paper itself

Abstract

Reactive oxygen species (ROS) are produced in growth factor-signaling pathways leading to cell proliferation, but the mechanisms leading to ROS generation and the targets of ROS signals are not well understood. Using a focused siRNA screen to identify redox-related proteins required for growth factor-induced cell cycle entry, we show that two ROS-generating proteins, the NADPH oxidases NOX4 and DUOX2, are required for platelet-derived growth factor (PDGF) induced retinoblastoma protein (Rb) phosphorylation in normal human fibroblasts. Unexpectedly, NOX4 and DUOX2 knockdown did not inhibit the early signaling pathways leading to cyclin D1 upregulation. However, hours after growth factor stimulation, NOX4 and DUOX2 knockdown reduced ERK1 phosphorylation and increased levels of the tumor suppressor protein p53 and a cell cycle inhibitor protein p21 (Waf1/Cip1) that is transcriptionally regulated by p53. Co-knockdown of NOX4 or DUOX2 with either p53 or with p21 overcame the inhibition of Rb phosphorylation that occurred with NOX4 or DUOX2 knockdown alone. Our results argue that rather than primarily affecting growth factor receptor signaling, NOX4 and DUOX2 regulate cell cycle entry as part of a p53-dependent checkpoint for proliferation.

Indexed as

Cell CycleCell ProliferationCells, CulturedDual OxidasesGene Knockdown TechniquesHumansMitogen-Activated Protein Kinase 3Models, BiologicalNADPH Oxidase 4NADPH OxidasesPhosphorylationPlatelet-Derived Growth FactorRetinoblastoma ProteinRNA, Small InterferingSignal TransductionTumor Suppressor Protein p53Dual OxidasesDUOX2 protein, humanMitogen-Activated Protein Kinase 3NADPH Oxidase 4NADPH OxidasesNOX4 protein, humanPlatelet-Derived Growth Factorplatelet-derived growth factor ARetinoblastoma ProteinRNA, Small InterferingTumor Suppressor Protein p53

Identifiers

PMID20531308
PMCPMC2916958
OpenAlexW2033574377

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.